The Secretary of Health and Human Services (referred to in this section as the "Secretary") shall identify or facilitate the development of best practices for-
The Secretary shall award grants on a competitive basis to eligible entities to support implementation of voluntary programs for care and treatment of individuals after a drug overdose, as appropriate, which may include implementation of the best practices described in subsection (a).
In this section, the term "eligible entity" means-
An eligible entity desiring a grant under this section shall submit an application to the Secretary, at such time and in such manner as the Secretary may require, that includes-
An eligible entity awarded a grant under this section shall use such grant funds to-
In addition to the uses described in paragraph (4), a grant awarded under this section may be used, directly or through contractual arrangements, to provide-
In awarding grants under this section, the Secretary shall give preference to eligible entities that meet any or all of the following criteria:
A grant awarded to an eligible entity under this section shall be for a period of not more than 5 years.
In this section:
The terms "Indian Tribe" and "tribal organization" have the meanings given the terms "Indian tribe" and "tribal organization" in section 5304 of title 25.
the 1 term "recovery coach" means an individual-
The term "recovery community organization" has the meaning given such term in section 290ee-2(a) of this title.
Each eligible entity awarded a grant under this section shall submit to the Secretary an annual report for each year for which the entity has received such grant that includes information on-
Not later than 5 years after October 24, 2018, the Secretary shall submit to Congress a report that includes an evaluation of the effectiveness of the grant program carried out under this section with respect to long term health outcomes of the population of individuals who have experienced a drug overdose, the percentage of patients treated or referred to treatment by grantees, and the frequency and number of patients who experienced relapse, were readmitted for treatment, or experienced another overdose.
The requirements of this section, including with respect to data reporting and program oversight, shall be subject to all applicable Federal and State privacy laws.
There is authorized to be appropriated to carry out this section $10,000,000 for each of fiscal years 2019 through 2023.
1 So in original. Probably should be capitalized.
42 U.S.C. § 290dd-4
EDITORIAL NOTES
REFERENCES IN TEXTThe Federal Food, Drug, and Cosmetic Act, referred to in subsec. (b)(4)(B), (5)(A), is act June 25, 1938, ch. 675, 52 Stat. 1040, which is classified generally to chapter 9 (§301 et seq.) of Title 21, Food and Drugs. For complete classification of this Act to the Code, see section 301 of Title 21 and Tables.
CODIFICATIONSection was enacted as part of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, also known as the SUPPORT for Patients and Communities Act, and not as part of the Public Health Service Act which comprises this chapter.
- Service
- The term "Service" means the Public Health Service;
- practices
- The term "practices" means design, financing, permitting, construction, commissioning, operation and maintenance, and other practices that contribute to achieving zero-net-energy buildings or facilities.
- Director
- the term "Director" means the Chief Executive Officer of the Corporation for National and Community Service,
- Secretary
- the term "Secretary" means- (A) the Secretary of Education for purposes of subtitle A (other than section 3201),(B) the Secretary of Agriculture for purposes of the amendments made by section 3201, and(C) the Secretary of Health and Human Services for purposes of subtitle B,
- drug
- the term "drug" means- (A) a beverage containing alcohol,(B) a controlled substance, or(C) a controlled substance analogue,